Dr. Georg Zenner
Georg Zenner is co-founder of Zenner Life Science Partner GmbH and since 2007 he holds the position as chief executive officer. During his career he worked in many different functions with increasing responsibilities including senior management positions in the pharmaceutical industry like Hoffmann-La Roche, Novartis, GlaxoWellcome, GlaxoSmithkline and an API manufacturer. Amongst many other positions he worked as Medical Manager, Product Manager, International Product Manager, Marketing Director, BU Director and International Business Leader and was leading multinational and cross-functional teams representing more than 90 countries. He successfully launched several products, re-launched products and managed several blockbuster products (sales > 1 billion US$). During his career he also worked closely together with opinion leaders and implemented and conducted advisory boards. He also gained experience in an academic environment when he worked as a scientist at the Max-Planck-Institute of immunology and gave lectures at the University.
His academic education started in Germany at the University of Marburg/Lahn in the medicine area (Human Biology/theoretical medicine) where he graduated in pharmacology and immunology. He gained his first business experience at Boehringer Ingelheim and at a Biotech company (Orpegen in Heidelberg). During his PhD thesis he worked in the field of immunology / oncology / cell biology in Switzerland combined with several years in the US.
He got further in depth training in marketing, finance including valuation (University of Zurich) and project management. By continuous education he is keen to hold his knowledge up to date e.g. in regulations for promoting medical products, clinical studies, marketing. One of his assets are his scientific and medical knowledge combined with marketing expertise and business understanding.
Core areas: strategy, executive management positions including change management, medical affairs (all therapeutic areas), marketing, operational tasks, training of people, business development (in-licensing, out-licensing), support for M&A, project management, reorganisation, process optimisation, B2B business, complete understanding and in depth knowledge of the whole drug development process from basic research and drug development via clinical studies (phase I to phase IV), regulatory affairs up to marketing and selling off the product .
Academic education / University degree:
Pharmacologist (Immunology, Oncology)
Certificates/Continued education:
